Breast Cancer Type’ Is Determined By Cell Shape And Appearance
Breast cancers or carcinomas are mainly of epithelial cell origin.
Epithelial cells are the lining of most of our organs and vessels.
However, there are quite a few very rare types of breast cancers which are comprised of non-epithelial cells . Furthermore, a great many breast cancers are actually not pure, but rather a mixture of different types of cells.
In general, there are six types of standard breast carcinomas, and statistically, some of these tend to show a better prognosis than others.
The six most common types of breast cancer are as follows:-
What Is Invasive Lobular Carcinoma
Invasive lobular carcinoma is a cancer that starts in the breasts lobules and invades surrounding tissue. ILC is the second most common form of invasive breast cancer, accounting for 10 to 15% of breast cancer cases. ILC doesnt always form a lump, but women who have it may notice a thick or full area that doesnt feel like the rest of the breast.
What Are The Different Types Of Breast Cancer
Breast cancer is the most frequently diagnosed life-threatening cancer in women and the leading cause of cancer deaths among women. Breast cancer types are divided into two main categories:
Noninvasive breast cancer
Noninvasive cancer forms within the milk ducts or lobules in the breast. Although healthy breast tissue is not yet affected, the cancer may progress at any time and immediate treatment is crucial.
There are two main types of noninvasive breast cancer:
Invasive breast cancer
Invasive breast cancer is breast cancer that has spread outside the ducts and lobules into the surrounding tissues. Types of invasive breast cancer include:
You May Like: How Likely Is Skin Cancer
How Is Inflammatory Breast Cancer Diagnosed
Inflammatory breast cancer can be difficult to diagnose. Often, there is no lump that can be felt during a physical exam or seen in a screening mammogram. In addition, most women diagnosed with inflammatory breast cancer have dense breast tissue, which makes cancer detection in a screening mammogram more difficult. Also, because inflammatory breast cancer is so aggressive, it can arise between scheduled screening mammograms and progress quickly. The symptoms of inflammatory breast cancer may be mistaken for those of mastitis, which is an infection of the breast, or another form of locally advanced breast cancer.
To help prevent delays in diagnosis and in choosing the best course of treatment, an international panel of experts published guidelines on how doctors can diagnose and stage inflammatory breast cancer correctly. Their recommendations are summarized below.
Minimum criteria for a diagnosis of inflammatory breast cancer include the following:
- A rapid onset of erythema , edema , and a peau d’orange appearance and/or abnormal breast warmth, with or without a lump that can be felt.
- The above-mentioned symptoms have been present for less than 6 months.
- The erythema covers at least a third of the breast.
- Initial biopsy samples from the affected breast show invasive carcinoma.
Imaging and staging tests include the following:
Types Of Breast Cancer
There are many types of breast cancer, and many different ways to describe them. Its easy to get confused over a breast cancer diagnosis.
The type of breast cancer is determined by the specific cells in the breast that are affected. Most breast cancers are carcinomas, which are tumors that start in the epithelial cells that line organs and tissues throughout the body. When carcinomas form in the breast, they are usually a more specific type called adenocarcinoma, which starts in cells in the ducts or the lobules .
Read Also: Does Skin Cancer Itch Or Hurt
Stage 1b Breast Cancer Means One Of The Following Descriptions Applies:
Lymph nodes have cancer evidence with small clusters of cells between the approximate size of a pinprick to the approximate width of a grain of rice .
AND EITHER No actual tumor is found in the breast.
OR The tumor is smaller than the approximate size of a peanut .
Similar to stage 0, breast cancer at this stage is very treatable and survivable. When breast cancer is detected early, and is in the localized stage , the 5-year relative survival rate is 100%.
How Is Prognosis Estimated
Prognosis is estimated by looking at what has happened over many years to large groups of people diagnosed with a similar cancer. However, everyones situation is different so no one can say for certain what will happen to you. Also, treatments and survival rates are constantly improving, which affects the accuracy of estimates for people being treated today.
Prognosis is described in different ways. It may be put into words or numbers. Its often expressed as a five- or ten-year survival rate. This is an estimate of how many people are likely to be alive five or ten years following their diagnosis.
A 90% five-year survival rate means that 90 out of 100 people diagnosed with breast cancer are likely to be alive five years after their diagnosis. It doesnt mean these people will only live for five years it just states how many people are likely to be alive at that point.
Cancer Research UK has general statistics on five- and ten-year breast cancer survival rates on their website. Remember, these statistics are based on large groups of patients and cannot predict what will happen in your individual case.
You May Like: What To Do If I Have Skin Cancer
Invasive Lobular Carcinoma Survival Rates
Survival rates for cancer are typically calculated in terms of how many people live at least 5 years after their diagnosis. The average 5-year survival rate for breast cancer is 90 percent, and the 10-year survival rate is 83 percent. This is an average of all stages and grades.
The stage of the cancer is important when considering survival rates. For instance, if the cancer is only in the breast, the 5-year rate of survival is 99 percent. If it has spread to the lymph nodes, the rate decreases to 85 percent.
Because there are many variables based on the type and spread of cancer, its best to talk with your doctor about what to expect.
What Is Ductal Carcinoma In Situ
Ductal carcinoma in situ is a very early form of breast cancer thats confined to the milk ducts, which is why its called ductal. Carcinoma is the name for any cancer that begins in cells that line the inner or outer surfaces of tissues, such as the breast ducts. In situ is a Latin term meaning in its original place. DCIS is the most common form of noninvasive breast cancer.
DCIS is classified as low, intermediate, or high grade. Grades are based on what the cells look like under a microscope. The lower the grade, the more closely DCIS resembles normal breast cells. The higher the grade, the more different it is from normal cells. DCIS can sometimes involve the nipple, causing it to look red and scaly. This is a rare form of cancer known as Pagets disease of the breast .
In some women, DCIS may not progress to invasive cancer in their lifetime. This has fueled debate about DCIS about whether women with low-risk disease need any treatment, or if they could be safely checked with annual mammograms and breast exams to see if the cancer is progressing. Currently, the standard treatment for DCIS includes surgery, often a lumpectomy.
You May Like: What Are The Signs And Symptoms Of Melanoma
What Is My Estrogen Receptor And Progesterone Receptor Status
Your bodys hormones such as estrogen and progesterone may play a role in how your breast cancer progresses.
Normal cells are equipped with receptors that allow them to receive information from circulating hormones, similar to the way your phone picks up satellite signals. Cancer cells may also have hormone receptors, letting them tap into your bodys normal cell growth-regulating system.
Your ER/PR status is determined by testing a sample of breast cancer cells removed during a biopsy. If your breast cancer cells have estrogen and progesterone receptors if theyre ER/PR-positive then theyre capable of detecting estrogens signal and using it to fuel growth. If the cancer cells lack these receptors meaning theyre ER-/PR-negative they cant hear the growth-signaling message.
About 70% of breast cancer patients have positive ER/PR hormone status.
While being ER/PR-positive sounds bad, theres actually a benefit. Doctors can take advantage of the receptors presence. They can use an anti-estrogen drug that blocks the receptors and blocks estrogens growth signal. Or they can use other drugs like aromatase inhibitors that lower your bodys estrogen levels to deprive the cancer cells of fuel.
Additional Immunohistochemical Markers For Infiltrative Ductal Carcinoma With Central Necrosis
Most invasive breast cancers will lack both a basement membrane and myoepithelial cells.
However, in actuality, there are many breast cancers that produce basement membrane components.
In addition, there are several invasive cancer that have myoepithelial cell elements. So, when trying to determine if a suspicious breast cancer lesion featuring central necrosis is comedo DCIS or an infiltrative breast carcinoma with central necrosis, there are a number of myoepithelial markers that may help.
Common myoepithelial cell markers include:-
- S-100, smooth muscle actine
- SMM-HC, Calponin: Is probably the most specific myoepithelial cell marker
- HMW-CK. SMM-HC .
- CD10, p63
- P63: Is quite a useful marker in breast cancer differentiation because it stains the myoepithelial nuclei only, and also has high sensitivity and specificity.
Don’t Miss: What Is Infiltrating Ductal Carcinoma
Predictors For Breast Cancer Survival Rates
It has to be remembered that every single breast cancer patient has itsown , unique scenario. Thus, prognosis and breast cancer survival rates are a rough guide ONLY.
However, there are consistent predictors for breast cancer survival rates and these include:-
- The stage of breast cancer at the time of diagnosis
- The Grade of the breast cancer
- A patients age at diagnosis
What Is Tumor Grading
After surgery to remove the tumor, a doctor will check it and assign a grade to it. The grade depends on how closely the cancer cells resemble normal cells when viewed under a microscope. Low-grade cancer cells are similar to normal breast cells. Higher grade breast cancer cells look more different. They show the cancer is more aggressive.
The doctor will also test for estrogen receptors and progesterone receptors. This test will show whether the female hormones — estrogen and progesterone — influence the cancer cells. If the test is positive, it means hormones cause the cancer cells to grow. In that case, therapies to suppress or block hormones may help treat the cancer.
The cancer will also be tested for a gene called HER2. If itâs found, additional drugs like trastuzumab can be used.
Other tests will see if the cancer has spread from the breast to other areas of the body.
Don’t Miss: Where To Get Skin Cancer Screening
Is Invasive Ductal Carcinoma Fast Growing
invasive ductal carcinomainvasive ductal carcinomainvasive ductal carcinomagrow
Over time, invasive ductal carcinoma can spread to the lymph nodes and possibly to other areas of the body. According to the American Cancer Society, more than 180,000 women in the United States find out they have invasive breast cancer each year. Most of them are diagnosed with invasive ductal carcinoma.
Likewise, what stage is invasive ductal carcinoma? Specifically, the invasive ductal carcinoma stages are: Stage 1 A breast tumor is smaller than 2 centimeters in diameter and the cancer has not spread beyond the breast. Stage 2 A breast tumor measures 2 to 4 centimeters in diameter or cancerous cells have spread to the lymph nodes in the underarm area.
In respect to this, what is the survival rate of invasive ductal carcinoma?
Certain breast cancer subtypes have a better statistical prognosis
|breast cancer sub-type|
|Infiltrating lobular carcinoma|
How curable is invasive ductal carcinoma?
Stage 0 breast cancer, ductal carcinoma in situ is a non-invasive cancer where abnormal cells have been found in the lining of the breast milk duct. Ductal Carcinoma In Situ is very early cancer that is highly treatable, but if it’s left untreated or undetected, it can spread into the surrounding breast tissue.
What Are The Symptoms Of Inflammatory Breast Cancer
Symptoms of inflammatory breast cancer include swelling and redness that affect a third or more of the breast. The skin of the breast may also appear pink, reddish purple, or bruised. In addition, the skin may have ridges or appear pitted, like the skin of an orange . These symptoms are caused by the buildup of fluid in the skin of the breast. This fluid buildup occurs because cancer cells have blocked lymph vessels in the skin, preventing the normal flow of lymph through the tissue. Sometimes the breast may contain a solid tumor that can be felt during a physical exam, but more often a tumor cannot be felt.
Other symptoms of inflammatory breast cancer include a rapid increase in breast size sensations of heaviness, burning, or tenderness in the breast or a nipple that is inverted . Swollen lymph nodes may also be present under the arm, near the collarbone, or both.
It is important to note that these symptoms may also be signs of other diseases or conditions, such as an infection, injury, or another type of breast cancer that is locally advanced. For this reason, women with inflammatory breast cancer often have a delayed diagnosis of their disease.
Also Check: What Is Grade 3 Invasive Ductal Carcinoma
What Is Inflammatory Breast Cancer
As its name suggests, inflammatory breast cancer often causes the breast to become red, swollen, and inflamed. Some women with IBC also notice thickened or discolored breast skin with tiny dimples, puckers, or ridges that make it look like an orange peel. While the symptoms may sound like an infection, the real culprit is cancer that is blocking lymphatic vessels in the skin and breast tissue, causing a buildup of fluid and, in some cases, pain, discoloration, and sudden swelling of the breast. Also called inflammatory breast carcinoma or locally advanced breast cancer, IBC can spread quickly, making prompt diagnosis and treatment essential.
Prognosis And Predictive Factors Of Lcis
LCIS constitutes a risk factor and a nonobligate precursor for subsequent development of invasive carcinoma. Invasive carcinoma develops in 25%35% of patients observed for more than 20 years. The relative risk of subsequent development of invasive carcinoma among patients with LCIS ranges from 6.9 to 12 times than that in women without LCIS. Retrospective studies of 1,174 women having LCIS and treated by excision biopsy alone reported that 181 developed subsequent invasive carcinoma with almost equal risk of both. Both the types of breast carcinomas, ductal or lobular, arise from LCIS. The current recommended management for LCIS is, therefore, a lifelong follow-up with or without tamoxifen treatment.
Also Check: What Is Papillary Thyroid Carcinoma
Special Types Of Invasive Breast Cancers
Some invasive breast cancers have special features or develop in different ways that affect their treatment and outlook. These cancers are less common but can be more serious than other types of breast cancer.
Inflammatory breast cancer is an uncommon type of invasive breast cancer. It accounts for about 1% to 5% of all breast cancers.
How Is Invasive Breast Cancer Treated
Different things will determine the type of breast cancer treatment your doctor recommends, including:
- Size of the tumor
- Results of lab tests done on the cancer cells
- Stage of the cancer
- Your age and general health
- If youâve been through menopause
- Your own feelings about the treatment options
- Family history
Also Check: What Is Stage 2 Melanoma Skin Cancer
How Is Inflammatory Breast Cancer Treated
Inflammatory breast cancer is generally treated first with systemic chemotherapy to help shrink the tumor, then with surgery to remove the tumor, followed by radiation therapy. This approach to treatment is called a multimodal approach. Studies have found that women with inflammatory breast cancer who are treated with a multimodal approach have better responses to therapy and longer survival. Treatments used in a multimodal approach may include those described below.
What Should A Person With Stage 0 Or Stage 1 Breast Cancer Expect Regarding Treatment
Even though Stage 0 breast cancer is considered non-invasive, it does require treatment, typically surgery or radiation, or a combination of the two. Chemotherapy is usually not part of the treatment regimen for earlier stages of cancer.
Stage 1 is highly treatable, however, it does require treatment, typically surgery and often radiation, or a combination of the two. Additionally, you may consider hormone therapy, depending on the type of cancer cells found and your additional risk factors. Like stage 0, Chemotherapy is often not necessary for earlier stages of cancer.
Material on this page courtesy of National Cancer Institute
You May Like: What Does Nodular Melanoma Look Like
Data Acquisition And Patient Selection
We used the SEER dataset that was released in April 2015, which included data from 18 population-based registries and covered approximately 28% of U.S. cancer patients. Data for tumour location, grade and histology were recorded according to the International Classification of Diseases for Oncology Version 3 . The inclusion criteria used to identify eligible patients were the following: females aged between 18 and 79, unilateral breast cancer, breast cancer as the first and only cancer diagnosis, diagnosis not obtained from a death certificate or autopsy, only one primary site, pathological confirmation of infiltrating ductal carcinoma, not otherwise specified and papillary carcinoma with invasion , surgical treatment with either mastectomy, breast-conserving surgery or unknown type, known ER and PR statuses, American Joint Committee on Cancer stages IIII and known time of diagnosis from January 1, 2003 to December 31, 2012. Patients diagnosed with breast cancer before 2003 were excluded because the World Health Organization did not recognize IPC as a distinct pathological entity until 2003. In addition, patients who were diagnosed with breast cancer after 2012 were not included because the database was only updated up to December 31, 2012 and we wanted to ensure adequate follow-up time. A total of 233,171 patients were included. Of these patients, 524 were diagnosed with IPC and 232,647 were diagnosed with IDC.